aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in San Diego, California, Dexcom, Inc. is a medical device company dedicated to improving the lives of people with diabetes through innovative continuous glucose monitoring (CGM) systems. The company's core mission is to provide real-time glucose monitoring to help users manage their diabetes more effectively. Dexcom's flagship products include the Dexcom G6 and the recently launched Dexcom G7, which offer advanced features such as direct-to-Apple Watch connectivity and enhanced accuracy. The company targets the diabetic population, aiming to simplify diabetes management and improve health outcomes.
Dexcom has garnered support from notable investors and has established itself as a leader in the CGM market. The company's achievements include receiving FDA approvals for its devices and expanding its product availability globally. Dexcom's impact is significant, as its technology allows for better glucose management, reducing complications associated with diabetes. Through continuous innovation and a strong commitment to user experience, Dexcom has made a profound difference in the lives of diabetics worldwide.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Devices, Glucose Monitors
Technology
Analytics, Telemedicine
Tags
Healthtech, IoT
Model Types
Hardware, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Consumers
Geographic Exposure
Global
When was Dexcom founded?
Dexcom was founded in 1999.
Where is Dexcom’s headquarters located?
Dexcom’s headquarters is located in São Paulo, BR.
When was Dexcom’s last funding round?
Dexcom’s most recent funding round was for $1B (USD) in May 2023.
How many employees does Dexcom have?
Dexcom has 7600 employees as of Feb 6, 2024.
How much has Dexcom raised to-date?
As of July 05, 2023, Dexcom has raised a total of $1.4B (USD) since May 2, 2023.
Add Comparison
Total Raised to Date
$1.4B
USD
Last Update May 2, 2023
Last Deal Details
$1B
USD
May 2, 2023
Post Ipo Debt
Total Employees Over Time
7600
As of Feb 2024
Dexcom Address
São Paulo,
Brazil
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts